Exploring clinical profile and treatment outcome differences based on baseline smoking and alcohol co‐use status among individuals initiating medication for opioid use disorder treatment

Documenti analoghi

• Impact of study design decisions on identification of treatment initiators of medications for opioid use disorder
  di: Payel J. Roy, et al.
  Pubblicazione: (2025)
• Evaluating the optimal duration of medication treatment for opioid use disorder
  di: Corey J. Hayes, et al.
  Pubblicazione: (2026)
• Empirically contrasting urine drug screening‐based opioid use disorder treatment outcome definitions
  di: Laura Brandt, et al.
  Pubblicazione: (2024)
• Commentary on Schmidt et al.: Informed patient preference and prioritizing access to medications for opioid use disorder for pregnant individuals
  di: Jake R. Morgan, et al.
  Pubblicazione: (2024)
• A comparative study of treatment retention in opioid use disorder: Subcutaneous injectable versus sublingual buprenorphine
  di: Charles Deng, et al.
  Pubblicazione: (2025)